Evidence map›Paper›PMID 40119587›Full record

ArticleGlia2025

Hippocampal Astrocyte Morphology Follows an Unexpected Trajectory With Age in a Transgenic Rodent Model of Tauopathy.

Emma Augustin, Tatiana Vinasco-Sandoval, Miriam Riquelme-Perez, Damien Plassard, Mylène Gaudin, Gwenaëlle Aurégan, Julien Mitja, Sueva Bernier, Charlène Joséphine, Fanny Petit and 11 more

Abstract read
In one paragraph

Article in Glia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Emma AugustinUniversité Paris-Saclay, CEA, CNRS, MIRCen, Laboratoire Des Maladies Neurodegeneratives, Fontenay-aux-Roses, France.
Tatiana Vinasco-SandovalCEA, CNRS, DRF, IBFJ, IRCM, Laboratoire de Génomique et Radiobiologie de la Kératinopoeièse, Evry, France.ORCID 0000-0002-0189-0573
Miriam Riquelme-PerezUniversité Paris-Saclay, CEA, CNRS, MIRCen, Laboratoire Des Maladies Neurodegeneratives, Fontenay-aux-Roses, France.ORCID 0000-0002-9204-3088
Damien PlassardGenomEast Platform, Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), CNRS UMR 7104, INSERM U1258, Université de Strasbourg, Illkirch, France.
Mylène GaudinUniversité Paris-Saclay, CEA, CNRS, MIRCen, Laboratoire Des Maladies Neurodegeneratives, Fontenay-aux-Roses, France.
Gwenaëlle AuréganUniversité Paris-Saclay, CEA, CNRS, MIRCen, Laboratoire Des Maladies Neurodegeneratives, Fontenay-aux-Roses, France.
Julien MitjaUniversité Paris-Saclay, CEA, CNRS, MIRCen, Laboratoire Des Maladies Neurodegeneratives, Fontenay-aux-Roses, France.
Sueva BernierUniversité Paris-Saclay, CEA, CNRS, MIRCen, Laboratoire Des Maladies Neurodegeneratives, Fontenay-aux-Roses, France.
Charlène JoséphineUniversité Paris-Saclay, CEA, CNRS, MIRCen, Laboratoire Des Maladies Neurodegeneratives, Fontenay-aux-Roses, France.
Fanny PetitUniversité Paris-Saclay, CEA, CNRS, MIRCen, Laboratoire Des Maladies Neurodegeneratives, Fontenay-aux-Roses, France.
Caroline JanUniversité Paris-Saclay, CEA, CNRS, MIRCen, Laboratoire Des Maladies Neurodegeneratives, Fontenay-aux-Roses, France.
Anne-Sophie HérardUniversité Paris-Saclay, CEA, CNRS, MIRCen, Laboratoire Des Maladies Neurodegeneratives, Fontenay-aux-Roses, France.
Marie-Claude GaillardUniversité Paris-Saclay, CEA, CNRS, MIRCen, Laboratoire Des Maladies Neurodegeneratives, Fontenay-aux-Roses, France.
Agathe LaunayUniversité de Lille, Inserm, CHU Lille, Lille, France.
Emilie FaivreUniversité de Lille, Inserm, CHU Lille, Lille, France.
Luc BuéeUniversité de Lille, Inserm, CHU Lille, Lille, France.
Anne-Laurence BoutillierLaboratoire de Neurosciences Cognitives et Adaptatives (LNCA), Université de Strasbourg, Strasbourg, France.ORCID 0000-0002-2317-9280
David BlumUniversité de Lille, Inserm, CHU Lille, Lille, France.ORCID 0000-0001-5691-431X
Alexis-Pierre BemelmansUniversité Paris-Saclay, CEA, CNRS, MIRCen, Laboratoire Des Maladies Neurodegeneratives, Fontenay-aux-Roses, France.ORCID 0000-0001-7605-5225
Gilles BonventoUniversité Paris-Saclay, CEA, CNRS, MIRCen, Laboratoire Des Maladies Neurodegeneratives, Fontenay-aux-Roses, France.ORCID 0000-0002-2886-4228
Karine CambonUniversité Paris-Saclay, CEA, CNRS, MIRCen, Laboratoire Des Maladies Neurodegeneratives, Fontenay-aux-Roses, France.ORCID 0000-0001-9263-4366

Funding

Agence Nationale de la Recherche ANR-11-INBS-0011 - NeurATRISAgence Nationale de la Recherche ANR-18-C816-0008-03Association France Alzheimer CEA CJ2022-0590
6 · The paper itself

Abstract

Individual protoplasmic astrocytes have very complex and diverse spongiform shapes. The morphological diversity of astrocytes is determined by the structural and functional interactions of the astrocyte with its microenvironment. When faced with pathological conditions, astrocytes reorganize their morphology. Yet, little is known about the astrocytic response in pure tauopathies and its evolution over time. Here, we aimed to investigate the consequences of a primary neuronal tau pathology on astrocyte fine morphology at three stages of the disease using the transgenic Thy-Tau22 mouse model. We first showed that hippocampal astrocytes in Thy-Tau22 mice progressively accumulate hyperphosphorylated tau with age. We then developed a pipeline of analyses, including 3D reconstruction of hippocampal tdTomato-labeled astrocytes via a PHP.eB adeno-associated virus, confocal microscopy, Imaris software morphometric analysis, and an advanced statistical analysis. During normal aging, the complexity of astrocyte morphology peaked at adulthood, then declined. In contrast, in Thy-Tau22 mice, tauopathy was associated with a simpler initial morphology, followed by the appearance of a cluster of complex cells at the most advanced stage. Using principal component analysis and hierarchical clustering based on 10 morphological features, we were able to identify different astrocyte morphotypes whose relative proportion varies differently with age between WT and Thy-Tau22 mice. Interestingly, we revealed that a fraction of astrocytes with a complex morphology re-emerges late in tauopathy-affected animals. Our data highlight the concept of significant and reversible structural plasticity of astrocytes when faced with chronic pathological conditions.

Indexed as

AgingAstrocytesHippocampusTauopathiesAnimalsDisease Models, AnimalHumansMaleMiceMice, Inbred C57BLMice, Transgenictau Proteinstau Proteinsagingastrocytesmorphologytau

Identifiers

PMID40119587
PMCPMC12121468

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.